Protein matrices engineered for control of cell and tissue behavior. by DiZio, Kathleen A.
University of Massachusetts Amherst
ScholarWorks@UMass Amherst
Doctoral Dissertations 1896 - February 2014
1-1-2003
Protein matrices engineered for control of cell and
tissue behavior.
Kathleen A. DiZio
University of Massachusetts Amherst
Follow this and additional works at: https://scholarworks.umass.edu/dissertations_1
This Open Access Dissertation is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in
Doctoral Dissertations 1896 - February 2014 by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Recommended Citation
DiZio, Kathleen A., "Protein matrices engineered for control of cell and tissue behavior." (2003). Doctoral Dissertations 1896 - February
2014. 1047.
https://scholarworks.umass.edu/dissertations_1/1047

UMASS.
DATE DUE
UNIVERSITY LIBRARY
UNIVERSITY OF MASSACHUSETTS
AMHERST
SCIENCE
LD
3234
M267
' D6255
PROTEIN MATRICES ENGINEERED
FOR CONTROL OF CELL AND TISSUE BEHAVIOR
A Dissertation Presented
by
KATHLEEN A. DI ZIO
Submitted to the Graduate School of the
University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of
DOCTOR OF PHILOSOPHY
February 2003
Polymer Science and Engineering
Copyright by Kathleen A. Di Zio 2003
All Rights Reserved
PROTEIN MATRICES ENGINEERED FOR CONTROL OF CELL AND TISSUE
BEHAVIOR
A Dissertation Presented
by
KATHLEEN A, DI ZIO
Approved as to style and content by:
David A. Tirrell, Chair
David Gross, Niember
Alan J. Lesser, Member
Thomas J. McCarthy, Department Head
Polymer Science and Engineering
ACKNOWLEDGEMENTS
I will begin by thanking my advisor David Tiirell for providing me with the
opportunity to achieve this goal. His gentle guidance and unrelenting support have
served as a foundation for my scientific and personal development. He has instilled a
strong mdependence and unwavering integrity that will serve me well in future
endeavors.
I would also like to thank my committee Alan Lesser and David Gross for their
valuable advice, perspectives, and understanding.
The many group members in the Tirrell Laboratory, past and present, have
provided much influential personal and scientific advice. Their friendships, opinions, and
conversations have been mind broadening and fulfilling. Friends from both within and
outside of the laboratory have helped me maintain a healthy perspective and balance.
Their belief in me has often granted me well-timed encouragement.
My family has remained the backbone ofmy support over these years. Their
undying confidence and faith in me have served as a necessary reassurance.
Most of all I would like to thank my husband, Mark Brongersma, for being the
person he is.
ABSTRACT
PROTEIN MATRICES ENGINEERED
FOR CONTROL OF CELL AND TISSUE BEHAVIOR
FEBRUARY 2003
KATHLEEN A. DI ZIO. B.S., UNIVERSITY OF CALIFORNIA SANTA BARBARA
M.S. UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor David A. Tirrell
Genetic engineering of artificial extracellular matrix (ECM) proteins represents an
exciting avenue for the preservation and control of the specificity of natural polymers on
a molecular level. This work focuses on controlling the mechanical and cell adhesion
properties of artificial extracellular matrices intended for vascular graft applications.
Genetic engineering methods were used for the design and preparation of artificial
proteins containing sequences chosen to mimic elements of the ECM. The cell-binding
domains (CBDs) of fibronectin impart biologic function, while an elastin-like repeat,
[(VPGIG)2(VPGKG)(VPGIG)2] provides mechanical properties and sites for covalent
crosslinking.
Three proteins were constructed using this design that differ only by the CBD.
The CBDs chosen for the proteins were the CSS domain, the scrambled CS5 (SC5)
domain, and the CSl domain and are denoted by the respective CBDs The SC5 protein
was prepared as a negative control for the CSS protein to assure cell adhesion was
V
mediated by the CSS domain. The CSl domam binds the same integrin as the CSS with a
20 - 1 00 fold higher affinity.
Bis(sulfosuccinimidYl)suberate and disuccinimidyl suberate were used to
crosslink protein films for mechanical testing. By varying the amount of crosslinker and
protein weight fraction, films were prepared with Young's moduli ranging from 0.06
MPa to 0.97 MPa. The molecular weight between crosslinks (Mc) was calculated to lie
between 3,000 and 38,000. The moduli and Mc of the proteins span the range reported
for natural elastin. Thiolating the lysines in CSS with N-succinimidyl S-acetylthioacetate
allowed investigation of the effect of disulfide crosslinking on the mechanical properties.
The modulus of the disulfide crosslinked films was 0.48 MPa corresponding to a Mc of
6000.
Adhesion studies of human umbilical vein endothelial cells (HUVEC) showed
increased and stronger adhesion to the CSS protein over the SCS protein. HUVEC
adhesion to the SCS was similar to the negative control (BSA) with very low or no
adhesion. HUVEC adhesion to the CSS ranged from the same as fibronectin to lower
than fibronectin as the detachment force was increased. These studies indicated adhesion
was mediated by the CBD since the proteins were otherwise identical.
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CHAPTER 1
INTRODUCTION: VASCULAR GRAFTS
1.1 Motivation
Degenerative diseases of the arteries, arterioles, and capillaries are responsible for
2% of all deaths annually [1]. In an effort to treat these diseases, there are more than
500,000 vascular grafts implanted yeariy in the United States [2, 3]. Large diameter
vascular grafts introduced to areas of high blood flow remain patent for many years.
Conversely, grafts with diameters less than 6 mm have been plagued by failure through
thrombosis and intimal hyperplasia [4]. Despite the large demand and over forty years of
research, an acceptable synthetic material for small diameter grafts does not exist.
Most grafting success has been realized through the use of the autologous
saphenous vein. Although this is currently the most desired material, the demand
severely exceeds the availability [4, 5]. Recent studies show that 28 % of patients have
an unusable or absent saphenous vein [6]. The lack of adequate saphenous vein and its
potential, preferential use are motivation enough for the development of an adequate
alternative. In addition, 30 % of saphenous vein grafts stenose within five years [7].
This unsatisfactory patency rate combined with the unavailability of the saphenous vein
has driven the focus of much research toward finding a new graft material.
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1.2 History
The first successful application of a synthetic vascular grafl was reported in 1952.
Vinyon N was used to replace a section of the artety that was believed to be a simple
conduit through which blood passed [8]. Research has since focused on developing
materials that were biologically inen, when it was believed that biocompatible mean,
minimizing interactions with the body. Cu„ently, researchers have concentrated on the
design of a biointeractive material, which provides the appropriate biological signals,
subsequently redefining the term "biocompatible." Nonetheless, biomaterials that have
predominated in the last decade are dated and far behind the revolution that has evolved
in the basic sciences. It seems the rate-limiting step in the clinical application of new and
effective biomaterials is the discovery of truly biocompatible implants and prostheses [9].
1.3 Current Graft Materip^k
Application of current synthetic vascular graft technologies yields high failure
rates. Despite the many materials that have been explored, expanded
polytetrafluoroethylene (ePTFE) and Dacron have remained dominant [4]. Although
these materials prove suitable for large diameter grafts, they are inadequate in small
diameter (< 6 mm) applications, leading to thrombosis and intimal hyperplasia. For
reasons that are currently unknown, migratory activity of the native endothelium ceases
after the cells have migrated approximately one centimeter into the graft; a phenomenon
observed in all animal species including man [10]. The surface spanning this centimeter
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remains antithrombogenic at both the proximal and distal ends of the graft, leaving the
thrombogenicity of the intennediate portion unaffected [10]. Depending on the study,
and animal used, untreated ePTFE grafts show 100 % failure rates at 12 weeks in dogs
[1 1] to six and a half years in humans [12].
In an effort to reduce failure rates, attempts have been made to endothelialize or
promote endothelialization of the graft. Initial strategies concentrated on graft
pacification, using various protein coatings to minimize blood/biomaterial interactions.
The surfaces of existing grafts were modified by impregnation with albumin [13], gelatin
[14], and collagen [15], clottmg with whole blood [16], or treatment with fibrin glue [17].
More recently, preseeding grafts with endothelial cells in the operating room [18] or
establishing a confluent layer of endothelial cells prior to implantation [19] has been
demonstrated in humans. The establishment of the confluent monolayer of endothelial
cells has produced patency results comparable to that of saphenous vein [12]. Although
these results are promising, a five-year failure rate of 30 % remains unsatisfactory.
Although the creation of a confluent monolayer improves long-term patency of
grafts, it is evident that the existence of this monolayer alone is not sufficient. Several
factors can induce a procoagulant state in the endothelium. Such stimuli include
mechanical trauma, bacterial endotoxins, and inflammatory mediators [20, 21].
Endothelial cells are capable of releasing smooth muscle cell mitogens that can cause
elevated mitotic activity [22-25].
In addition to biological considerations, the mechanical properties of a small
diameter synthetic graft are a primary concern. The graft must withstand physical
demands of its environment, requiring crush strength and flexibility for cross-joint
applications, and maintaining mechanical integrity during long-term pulsatile stress and
the load imposed by lumen pressure. Another important matter is the hemodynamic
trauma imposed on the endothelium by a compliance mismatch between the graft and
native vessel, leading to thrombus formation and intimal hyperplasia [26-30]. This
indicates the dependence of the cell physiology on the mechanics of the material and the
significance of incorporating both bioactive and biomechanical properties into the design
of small diameter vascular grafts.
Polyurethanes have been the subject of recent studies in an effort to reduce the
compliance mismatch between native vascular materials and biomaterials. Polyurethanes
are used in a variety of blood-contacting biomaterials, including catheters, blood filters,
and blood tubing [31, 32]. These materials provide strength, moldability, and elasticity
but are known to activate platelets. The platelet reactivity has been decreased by
blending polyurethane with poly(tetramethylene oxide) [31]. This material appropriately
addresses the compliance mismatch issue, but does not possess the necessary biologic
signals to maintain a healthy endothelium.
Another route to address the biological and biomechanical considerations for a
synthetic vascular graft is the use of completely biological materials. Endothelial cells
and smooth muscle cells will grow their own extracellular matrix in culture [33].
Layered, tubular structures have been created, producing well-defined tissues including
the intima, media, and adventitia [34]. Some of the drawbacks of this structure for use as
a vascular graft are a three-month preparation time and compliance mismatch from that
of native vessels. Although this approach seems promising, the research is still in the
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very early stages, and the time required for regeneration of a vessel by entirely
autologous or cell-derived components makes the technique impractical.
It seems reasonable that an effective vascular graft might first serve as a simple
scaffold to provide the appropriate biological signals and the necessary mechanical
integrity for the vessel to eventually rebuild itself into a natural organ. In addition to
biological signals, biocompatibility and biodegradability must be built into the material
For use in clinical applications this material must be available at the time of demand.
Success will likely rely on the incorporation of synthetic as well as biological aspects.
Progress is rapidly being achieved m the search for factors that control thrombus
formation, intimal hyperplasia, and angiogenesis; this will undoubtedly lead to the
production of a more acceptable material for vascular grafts.
1.4 Background
In an effort to create the enviromnent for a healthy endothelium, researchers have
looked more closely at specific cell-extracellular matrix (ECM) interactions. An
understanding of the molecular basis of cell adhesion should provide some insight into
the role of these interactions during normal development and growth, as well as in
disease states. Integrins are a group of sequence-related proteins that are involved in cell-
ECM and cell-cell adhesion. The ECM-receptor integrins are heterodimers composed of
a number of different a and p subunits [35]. The composition of the ECM determines
which integrins are included in focal contact formation during cell adhesion. Integrins, a
word formulated to represent the integration of the ECM and the cytoskeleton, affect the
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cell's activities with respect to their extracellular environment. Integrins arc an
important component in cellular signal transduction and are involved in remodeling
associated with wound healing and angiogenesis [36]. The attachment of human
umbilical endothelial cells (HUVEC) on fibronectin through integrins causes the cells to
set up
-micro-compartments" for protein synthesis in the region of the integrin receptor
[37]. This indicates imegrins play an important role in the formation of proteins and
ensuing regeneration of the ECM by the cell. It would seem necessary to involve
integrins in the biological signals provided by a scaffold that allowed the regeneration of
a natural ECM.
Recently there has been appreciable progress toward elucidating the biochemical
nature of the interaction of cells with purified ECM components. Fibronectin, a
multiftinctional protein found in the ECM and blood serum contains many cell-adhesion
domains [38]. REDV is the minimal active sequence in the CSS domain of fibronectin
known to bind the a,p, integrin [39-42]. This peptide is of particular interest because in
culturing studies it has been shown to adhere HUVEC but not smooth muscle cells
(SMC), platelets, or fibroblasts [43, 44]. In fact, immobilization ofGREDVY on
glycophase glass has produced surfaces that selectively attach HUVEC and not
fibroblasts, smooth muscle cells (SMC) or platelets [44]. In order to explore the role of
receptor-ligand affinity, another cell-adhesion domain of interest is the CSl segment of
fibronectin. The CSl domain is also known to bind the a^^] integrin, but with a 20-100
fold higher affinity than the CS5 domain [42]. It is possible that a material incorporating
CS5 or CSl domains would support selective attachment ofHUVEC and bypass
thrombus formation or intimal hyperplasia.
RGD is another sequence found in the central cell-binding domain of fibronectin,
which can adhere a variety of cell types, including endothelial cells, through asP, and
avPs integrins [40, 45]. Grafting RGD peptides to ePTFE surfaces improves endothelial
cell adhesion in vitro [46].
Due to the limited time available for endothelial cells to attach and spread to graft
surfaces in a clinical enviromnent, factors that promote rapid and strong adhesion need to
be examined. Altering the receptor-ligand affinity is one approach to increase the
adhesion strength. The conformation of the peptide seems to play an integral role in cell
attachment. When Hubbell et al. grafted the GRGDY peptide on glass through the C-
terminus rather than the N-terminus, it showed a higher affinity to attach platelets [47].
Xiao and Truskey showed the immobilization ofRGD on glass illustrated a higher
affinity of the surface for bovine endothelial cell adhesion when attached in a cyclic form
instead of a linear one [48]. This indicates that the presentation of the sequence is
important for receptor recognition. It is possible that the looped presentation is more
analogous to the native conformation, which is within the backbone of the fibronectin
molecule. This suggests integradon of a bioactive sequence into the backbone of a
material may result in higher cell adhesion than for a material with the grafted peptide.
In addition to the integrin-binding domains, many naturally occurring ECM
proteins contain heparin-binding domains [49-52]. It has been shown that heparin not
only exhibits anticoagulant activity, but also serves as a potent and specific inhibitor of
SMC proliferation [53, 54]. Specifically, the pepdde sequence
RYVVLPRPVCFEKGMNYTVR has been identified in murine laminin to bind heparin
and aid adhesion of cells when immobilized on polystyrene [55]. It is believed heparin-
sulfate proteoglycans present on the cell surfaces bind to the heparin-binding domains
and promote the formation of cellular, focal-adhesion contacts [56].
Coincident to the biological features ofECM proteins, structural features have
also been examined. A natural blood vessel consists of an intima with an endothelial cell
layer, a media that is primarily elastin and smooth muscle cells, and an adventitia that is
mainly collagen and fibroblasts. Elastin is a major component of the elastic lamina of
small muscular arteries found directly adjacent to the endothelium. It is a fibrous protein
found within arterial walls, ligaments, and other connective tissue with its principal
fiinction to provide elasticity and resilience [57]. The high content of hydrophobic
residues makes elastin one of the most chemically and proteinase-resistant proteins in the
body. In a natural artery the mechanical strength to withstand the load imposed by the
lumen pressure is provided by the vessel's elastin structure and the contractile force of
the smooth muscle cells [58]. In contrast to the modulus of ePTFE (600 MPa), naturally
occurring elasfin has a modulus of 0.3 MPa - 0.6 MPa [59].
The sequence VPGVG has been shown to repeat up to eleven times consecutively
in native elastin [60]. The exploradon of elastin-like sequences has produced materials
with a large span of mechanical properties. Reported elastic moduli for crosslinked
samples encompass a range of values from 10"^ to 10^ dynes/cm2 depending on sequence
and water content [61]; a range encompassing moduli recorded for that of the arterial wall
[62]. The water solubility of these materials allows facile processing for evaluation of
materials properties, films, and device formation [63]. Poly(VPGVG) has been
extensively studied with regard to mutagenicity, toxicity, antigenicity, pyrogenicity, and
thrombogenicity with promising performance [60].
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Elastin-like materials may be favorable for vascular graft applications because of
their mechanical characteristics and ability to build in cell-specific interactions. Whereas
poly(VPGVG) is non-adhesive towards HUVEC, variants that contain periodic GRGDS
inserts exhibit adhesion [64]. The non-adhesive behavior of elastm-like materials could
allow the insertion of only the desired function of the cell-adhesion protein, permitting
cell-type selectivity that is otherwise unattainable. Similar insertion of the REDV
sequence did not produce adhesive substrates [65]. This may be a result of the inability
of the short insert to adopt the proper conformation since analogous sequences
incorporating the entire region of the CSS domain show adhesive behavior toward
HUVEC [66].
Even though the individual cell types of the arterial wall may be easily cultured and
the protein components isolated, the production of a cohesive, three-dimensional
structure with mature extracellular-matrix (ECM) elastic tissue layers has been a major
technological obstacle [67]. This may in part be a result of the tendency to use existing
materials where the original design intent of these materials is usually um-elated to the
biomedical application. It should be possible to engineer a material that incorporates the
necessary biological and mechanical characteristics for a small diameter vascular graft.
1.5 Artificial Extracellular Matrix Proteins
Natural polymers possess properties inherently difficult to reproduce in synthetic
macromolecules. However, natural biosynthetic machinery can be harnessed and
manipulated to synthesize protein polymers with specific sequences, molecular weights
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and fiinctionalities [68]. Here we have designed artificial ECM proteins to produce a
material with both biologic and mechanical fonctionality. To impart these characteristics,
two naturally occurring ECM proteins, fibronectin and elastin were used to derive the
artificial ECM sequence.
The design presented here is based on the material prepared by Alyssa Panitch.
Panitch's design incorporated CSS domains from fibronectin interspersed at controlled
intervals in a VPGIG elastin-like matrix material. Varying the VPGVG pentapeptide
repeat found in elastin by changing the fourth amino acid does not disrupt the elastin-like
behavior such as a lower critical solution temperature (LCST) [69]. A distinctive
characteristic of elastin-like polymers in aqueous solvents is the existence of an LCST
above which a polymer-rich coacervate forms and below which, the polymer is soluble.
The LCST is believed to be responsible for a significant aspect of the elasticity of the
protein [70]. The CSS domain, LDGEEIQIGHIPREDVDYLHPLKN, was chosen for its
selectivity to bind the a4Pi integrin and because the minimal active sequence, REDV
was found to adhere HUVEC, not SMC or platelets. The design utilized bacterial
synthesis to maintain exact control of the peptide sequence. Two materials were studied:
(CSS(VPGIG)x)y, x = 20, 40; y = 5, 3, respectively. These proteins demonstrated
promising adhesion behavior towards HUVEC. Both the number of cells attached and
the corresponding spreading of the adherent cells were evaluated. The (CSS(VPGIG)2o)5
which contains twice the number of CSS domains as the (CS5(VPGlG)4o)3 showed an
increase in the number of attached cells compared to the (CSS(VPGlG)4o)3 when coated
on glass (Figure 1.1) [66].
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Panitch's material maintained the LCST characteristic of elastin-like materials
[66]. The LCST can be shifted depending on the hydrophobicity of the fourth residue
[61]. Isoleucine was chosen in the VPGIG repeat because it was predicted to yield a
material with an LCST of lOX, which is below room temperature and ensured reduction
of water-solubility at physiological temperatures. The measured LCST for the materials
was 12°C for the higher CSS density and 13.4°C for the lower CSS density material. It
was hypothesized that the LCST below physiological temperature would stabilize surface
coatings of the protein at these conditions. Panitch showed the majority of protein cast in
films dissolved from the surface of glass cover slips even when formed above the LCST
[66]. Essentially, all but the amount that was adsorbed onto the surface was washed
away. Assuming a uniform coating, the surface layer would be approximately ten
nanometers in thickness, however, the low amounts of protein made it difficult to
evaluate film continuity. Field emission scanning electron microscopy (FESEM) and
energy dispersive x-ray spectrometry (EDX) were performed on CSS VPGIG20 coated
glass cover slips of with a JEOL 6320-FX field emission scanning electron microscope.
The FESEM micrographs illustrated that the surface of the films was rough and
inconsistent within the film. EDX analysis indicated that the amount of protein present
on the cover slip was not sufficient to produce a signal intensity that could be resolved
over that of the Si and O from the glass.
The desire to produce stable films and a material with appropriate mechanical
properties motivated the development of a crosslinking mechanism for the CSS VPGIG
constructs. The available methods for crosslinking these elastin-like materials are
limited. Physical crosslinking methods such as y-irradiafion have been used to crosslink
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VPGVG constructs [63]. Although this produces three-dimensional networks with
promising mechanical properties for vascular graft applications, it results in a low
crosslink density and is nonspecific [71]. It was shown that y-irradiation crosslinked
VPGVG constructs required incorporation of a higher RGD density to attain the same
cell-adhesion behavior as with the uncrosslinked materials [65].
Eosin Y has been used to crosslink BSA and collagen [72]. Attempts to
photochemically crosslink the CSS (VPGIG)^ constructs with Eosin Y as a
photosensitizer and triethanol amine as an electron donor failed to produce an insoluble
material.
Glutaraldehyde (GTA) and carbodiimide (GDI) with hexamethylene diamine
(HMDA) have been used extensively to crosslink collagen [73]. Although crosslinking
with GTA provides a convenient and effective means of crosslinking, degradation of the
protein during implantation releases monomeric GTA into the tissue, resulting in
cytotoxicity and inflammation [73]. Efforts to crosslink the CS5(VPGIG)x constructs
using GTA and CDI/HMDA techniques also failed to produce crosslinked materials.
Welsh introduced lysines into the N- and C-terminal regions of the
(CS5(VPGIG)2o)x proteins of varying lengths and crosslinked with glutaraldehyde
yielding films with tensile moduli analogous to natural elastin [74]. An elastin-like motif
was used by Conticello and coworkers where lysines were incorporated within a VPGVG
repeat and crosslinked to create elastin-mimetic hydrogels where the extent of
crosslinking with bifunctional N-hydroxysuccinimidyl (NHS) esters and swelling
behavior were characterized [75]. Urry and coworkers explored the swelling and
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mechanical behavior of various elastin-like proteins crosslinked by y-irradiation, dicumyl
peroxide and carbodiimide [76-78].
In an effort to make a material with the desired mechanical properties and further
explore the biologic effects of the cell-binding domains (CBD), the proposed design
introduces a crosslinking residue within the elastin-like region. The replacement of a
lysine for every fifth isoleucine residue allows a mechanism for crosslinking the protein
and yields a repeated protein sequence as follows:
(CBD ((VPGIG)2 VPGKG (VPGIG)2)4)3.
Incorporation of the lysine in this position would permit crosslinking within the elastin-
like sequence and potentially not affect the cell-binding behavior. The following CBD
will be incorporated into the above elastin-like motif: CS5, SC5, and CSl. The SC5
domain will serve as a negative control for the CSS, where the REDV part of the CSS is
scrambled to REVD in the SCS. In order to explore the role of ligand affinity, another
cell-binding domain of interest is the CSl domain of fibronectin. The CSl domain is also
known to bind the a4pi integrin, but with a 20-100 fold higher affinity [42].
The crosslinkable elastin-like structure will provide the mechanical integrity and
compliance while the CBD domain will impart the biological activity of the material.
The precisely controllable molecular architecture offers the ability to systematically alter
the material properties and further understand the requirements for a vascular graft.
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Substrate Adherent cells
Glass 2880 ± 1670
[CS5(VPGIG)J3 1150 ± 360
[CS5(VPGIG)2o]5 9170 ±1800
Fibronectin 10,140 ± 290
Figure 1 .
1 Number ofHUVEC attached to artificial ECM proteins indicating better
adhesion to the protein with a higher cell-binding domain density [66].
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CHAPTER 2
PREPARATION OF ARTIFICIAL EXTRACELLULAR
MATRIX PROTEINS
2.1 Introduction and Obj ectives
Genetic engineering methods were used for the design and preparation of artificial
proteins containing sequences chosen to mimic elements of the naturally extracellular
matrix (ECM). The CSS and CSl domains of fibronectin impart biologic function, while
an elastin-like repeat [(VPGIG)2(VPGKG)(VPGIG)2] provides mechanical properties and
covalent sites for crosslinking. These proteins were then expressed and purified on a
multi-gram batch scale. Bis(sulfosuccinimidyl)suberate and disuccinimidyl suberate
described for crosslinking the proteins specifically through the lysines.
are
2.2 Experimental Section
2.2.1 Genetic Manipulation
Standardized protocols were used in DNA manipulations, bacterial growth,
protein expression, SDS-PAGE and Western blotting [1].
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2-2.1.1 Design of Artificial npnp fi.ik
The following DNA sequence and corresponding amino acids were designed ,o
produce ,he (VPGIG).VPGKG(VPG1G). monomer designated El-IK with Ban I/EcoRI
and Banl/BamHI flanking regions for insertion into the cloning vector and
multimerization:
Eco RI Ban I
^^^^PGIGVPGIGVP
AA TTC TAA GGG GTG CCG GGT ATC GGC GTT CCG GGC ATC GGT GTA CCG
Ban I Bam HI
^KGVPGIGVPGIGVP
GGC AAA GGT GTT CCG GGC ATC GGT GTT CCG GGT ATC GGG GTG CCG
2-2.1.2 Preparation of Synthetic DNA
G
Genosys Biotechnologies, Inc. (Woodlands, Tx.) synthesized the oligonucleotide
El-IK by solid-state synthesis. The El-IK was annealed by heating to 95°C in annealing
salts for several minutes and then cooled slowly in a Styrofoam cooler to room
temperature. The DNA was then precipitated and phosphorylated with T4 polynucleotide
kinase. Phenol/chloroform extraction and subsequent isolation followed this on a 2%
agarose gel electrophoresis. The corresponding 93 bp fragment was excised and purified
from the agarose by the QiaexII protocol (Qiagen, 1994).
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Cloning and Amplificatinn nf
^yrnhgtir DMA
The purified El-IK was ligated into an Eco RI/Bam HI digested, dephosphorylated
PUC19 cloning vector (Figure 2.1) and transformed into the E. coli strain DH5a-f
. Cells
were grown at 37°C overnight on 2XYT solid medium containing 200ug/ml ampicillin.
The DNA was hawested from the transformants with Qiagen miniprep spin columns and
digested with Bam HI/Eco RI. The fi-agments were separated by agarose gel
electrophoresis on a 3% gel and a 93 bp fragment confirmed insertion. Three of these
transformants were chosen and sequenced using the CalTech Sequencing Facility with a
NEB M13/pUC sequencing primer #1212. One transformant was chosen which showed
no ambiguities in the sequencing chromatogram. The plasmid was designated pUC El-
IK,
2-2-1.4 Polymerization of El-IK Monomer and Cloning of El-IK Multimers
The pUC El-IK was digested with Ban 1 and the resulting 75 bp fragment was
separated on a 3 % agarose gel by electrophoresis. The fragment was excised and
purified with a QiaexII gel extraction kit and self-ligated to produce a population of
multimers. The tetramer (E1-IK)4 was separated on a 1.5% agarose gel by
electrophoresis, excised, and purified with a QiaexII gel extraction kit. The purified
tetramer was ligated into Ban I digested, dephosphorylated pEC CS5, pEC SC5, and pEC
CSl cloning vectors (Figure 2.2). Recombinant plasmids were used to transform the E.
coli strain DH5a-f and designated pEC CS5(E1-IK)4, pEC SC5(E1-1K)4, and pEC
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CS1(E1-IK)4. The colonies were screened by digestion with Sal 1/Xho 1 to produce
CS5(E1-IK)4, SC5(E1-1K)„ and CSl(El-IK). as visualized following separation on a 1 %
gel.
Construction of the RaoteH;,] Expression Vectnr^
The recombinant pEC CS5(E1-IK)4, pEC SC5(E1-IK)4, and pEC CS1(E1-IK)4
vectors were digested with Xho I/Sal I to obtain the CS5(EL-IK)4, SC5(EL-IK)4, and
CS1(EL-IK)4 cassettes. The cassettes were separated by agarose gel electrophoresis on a
1 % gel and recovered by extraction with QiaexII DNA extraction kit. The recovered
DNA was ligated into an Xho I digested, dephosphorylated pET-28rw vector (Figure 2.3)
and used to transform the E. coli strain DH5a-f
. Transformants were screened for
insertion and orientation of each cassette by digestion with Xho I/Xba I. Visualization of
the insert on a 1 % agarose gel by gel electrophoresis confirmed the presence of the
CS5(EL-IK)4, SC5(EL-IK)4, and CS1(EL-IK)4 cassettes. This step was repeated twice
more to create the pET28rw[CS5(EL-IK)4]3, pET28rw[SC5(EL-IK)4]3, and
pET28rw[CSl(EL-IK)4]3 recombinant plasmids. These plasmids were used to transform
the expression host E. coli strain BL21(DE3)pLysS.
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Protein Expression and Pnnfi^^tion
2.2.2,1 10 L Fermentatinn
Expression was carried out in a 10 L Bioflow 3000 (New Brunswick Scientific,
Edison, NJ) fennentor with Terrific Broth (TB) as the expression medium supplemented
with 25 mg/1 kanamycin (Sigma, St. Louis, MO) and 34 mg/1 chloramphenicol (Sigma,
St. Louis, MO). A 400 ml overnight culture was used for inoculation of the fermentation
culture. The pH was maintained at 7.2 and the temperature at 37 °C. The culture was
induced at an OD.oo of 5-6 with 2.5 mM IPTG and the expression was allowed to
continue 2-3 hours to reach an OD^oo of 13-18. The cells were harvested by
centrifugadon (15 min., 10,000 g, 4 X) yielding an average of 200 g wet cell mass per
fermentation. The protein expression for these constructs yields 13 mg/g wet cell mass.
2.2.2.3 Protein Purification
The protein purification flowchart is shown in Figure 2.4. The wet cell mass was
redispersed in TEN buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.1 M NaCl) at 0.5
g/ml, frozen, then thawed at 4 °C with addition of 10 ^ig/ml deoxyribonuclease 1 (Sigma,
St. Louis, MO), 10 ng/ml ribonuclease A (Sigma, St. Louis, MO), and 50 |ug/ml
phenylmethylsulfonyl fluoride (Sigma, St. Louis, MO). The solution was centrifuged (2
hr, 35,000 g, 4 °C) to separate soluble and insoluble fractions. The supernatant was
brought to pH 9 and 1 M NaCl at 4 °C, and then allowed to equilibrate to 37 °C before
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another centrifbgation (2 hr, 35,000 g, 37 ^C). The pellet was redispersed in distilled
water, brought to pH 9, 1 M NaCl at 4 °C and centrifbged (2 hr, 35,000 g, 4 °C). The
supernatant was then warmed to 37 °C and centrifuged (2 hr, 35,000 g, 37 °C). This
process was repeated twice with the pellet from this step. The resulting final pellet was
redispersed in distilled water, dialyzed for three days at 4 °C and lyophilized to yield the
purified product. SDS-PAGE, western blot, mass spectrometry, and amino acid analysis
were used to assess the purity and molecular weight of the proteins. Western blots were
detected with a horse radish peroxidase conjugated antibody for the T7 tag (Novagen,
Madison, WI). Matrix Assisted Laser Desorption lonization-Mass Spectrometry
(MALDI-MS) was conducted with a 1 :20 ratio of matrix solution (10 mg/ml sinapic acid
in 0.07 % trifluoroacetic acid, 30 % acetonitrile) to analyte solution (30 mg/ml protein in
4 °C water) on a Voyager DE spectrometer (Applied Biosystems). The plate was spotted
at 4 °C followed by crystallization at 4 °C for 1 hr and 25 °C for 2 hr prior to analysis.
Amino acid analysis was conducted at University of California at Davis Amino Acid
Analysis Facility.
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2.3 R^suIts_andDiscussion
2.3.1 Protein Expression and PnHfir>^t;..n
2.3.1.1 Expression and Yield of Prnt^in
Three proteins were made by genetic engineering as described and are shown in
Figure 2.5. Each protein is denoted by the cell-binding domain, i.e. CSS, SC5, and CSl,
respectively. Protein expression for these constructs yields approximately 13 mg/g wet
cell mass. This allows almost 3 grams of protein to be attained from one 10 L
fermentation.
2.3.1.2 Purification by the LCST
A distinctive characteristic of elastin-like polymers in aqueous solvents is the
existence of an LCST above which a polymer-rich coacervate forms and below which the
polymer is soluble. Cycling protein solutions above and below the LCST provides a
simple method of purification of elastin-like proteins [2-6]. Upon thawing the whole cell
lysate at 4 °C (below the LCST), the protein remains in solution, allowing separation of
insoluble contaminating proteins by centrifugation. Following pH adjustment and
addition of salt, raising the temperature to 30 °C (above the LCST) causes the protein to
precipitate, and soluble contaminating proteins can be removed by centrifugation.
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2.3.1.3 Measures of Purity
The purified CSS and SC5 proteins are shown on an SDS-PAGE gel and western
blot in Figure 2.6. Figure 2.7 shows the SDS-PAGE gel and western blot of CSl
. The
PAGE mobility of the proteins causes them to run at a higher molecular weight than
expected. This is consistent with previously prepared elastin-like proteins [7, 8]. Mass
spectrometry shows the molecular mass of CSS in Figure 2.8 and of SC5 in Figure 2.9,
both within instrumental error of the expected mass of 37120 Da. The amino acid
analysis of both CSS and SCS proteins is shown in Table 2.1 and the CSl in Table 2.2.
All mole %s are within 1 % of the expected resuh with the exception of valine in CSl.
The SDS-PAGE and mass spectrometry results along with the amino acid analysis
confirm the isolation of pure proteins of correct molecular weight and amino acid
composition.
2.4 Summary and Conclusions
The high expression level and simple, batch purification process allows multi-gram
quantities of pure proteins to be attained easily.
29
1 neoretical CSS SC5
N%N%
n/M 2 2.9 3.2
3.7 3.5 3.8oo 0.2 0.5 0.2n 32.8 33.3 32.4un 3.2 2.5 3
0.7 0.8 0.8T
1 0.2 0.1 0.3A 0.2 0.3p 17.1 18 18.1YT 1 .5 1.5 1.5
V 16.4 16.8 16.4
W 0 0.5
U 0 0 0
1
1 14.1 14.6 14.1
1
1 .7 1.8 1.9Cr U 0 0
w 0 0 0
K 3.2 3.4 3.5
TOTAL 98 100 100
Tabic 2.1 Amino acid analysis of CS5 and SC5 proteins showing amino acid
compositions within 1 mole % of expected.
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Theoretical wO 1
AMINO ACID N% MO/IN /o
ASP (D) 3.10 il 1 Q
GLU (E) 1.70
vJ.
ASN (N) 0.70 n on
SER (S) 1.00 u.oy
GLN (Q) 1.20 n on
GLY (G) 31.00 OU. / u
HIS (H) 3.10 O. 1 O
ARG (R) 0.00 u.uu
THR (T) 1.70
1 .OH
ALA (A) 0.20
PRO (P) 18.80 i Q
TYR (Y) 0.00 n nn
VAL (V) 16.60
1 9.U 1
MET (M) 1.00
CYS (C) 0.00 0 01
ILE(I) 12.30 12.08
LEU (L) 4.60 4.92
PHE (F) 0.00 0.00
TRP (W) 0.00 0.00
LSY (K) 3.10 3.33
TOTAL 100.10 100.00
Table 2.2 Amino acid analysis of CS 1 protein showing amino acid compositions
within 1 mol % of expected with the exception of valine that is within 1 5
mol %.
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EooRI
Figure 2.
1
Construction ofpUC El-IK plasmid by insertion of the El-IK fragment
into the pUC 19 plasmid at the Eco RI/Bam HI restriction sites.
32
Figure 2.2 Construction of the pEC CBD(E1-IK)4 plasmids by insertion of the
tetramer (EI-IK)4 into the pEC CBD plasmids at the Ban 1 restriction site
(where CBD = CSS, SC5, and CSl).
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Figure 2.3 Construction of the bacterial expression vector pET CBD(E1-IK)4.
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Whole Cell Lysate
- Thaw @ 4 C(Protein below LCST and in Solution)
I
Centrifuge
Supernatant
- Protein below LCST and in Solution
pH to 9, 1M NaCI, 25 C, Centrifuge
Repeat
" ""^^"^ Coacervate
Redisperse in H^O, pH to 9, 1M NaCI. 4 C, Centrifuge
Supernatant
- Protein below LCST and in Solution
twice
Diaiyse
i
Freeze
i
Lyophilize
Gram-Scale Synthesis
Figure 2.4 Purification flowchart showing a simple, batch purification to obtain
multi-gram quantities of target proteins.
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CSS:
Site
Cell-binding Elastin-like Repeat
Domain
SC5 :
M^ASMTGGQQMGHHHHHHH.DDDDK-(G^
T7Tag H.s Tag Cleavage Scrambled CSS Elastin-like Repeat
Site Cell-binding Domain
CS1
«-MASMTGGQa«G-H„„HHHH.DDDOK,LDDELPaLVTLPHP„LHGPE,LDVPST,,VPG,G,,VPGKG,VPaG,,U^
\f laa H.<:Ti.n r^.^.
Domain
T7Tag is ag Cleavage CSlCell-binding Elastin-like Repeat
Site nnmain
Figure 2.5 Three proteins were made by genetic engineering and are denoted by the
cell-binding domain CS5, SC5, and CS 1
.
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MW CSS GeCS5 BloSCS G«C5 Blot
gure 2.6 SDS-PAGE gel and western blot of the CS5 and SC5 proteins.
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MW Gel Blot
Figure 2.7 SDS-PAGE gel and western blot of the CSl protein.
20
10
^999
37150.74
18589.58
p«i*XU>.i.,«.4».
24000 43001
74329.09
It riiii.Wiii.i
(m/z)
62002 81003 100004
Figure 2.8 Mass spectrometry of the CSS protein, showing a peak at 37150, within
experimental error of the expected mass of 37120.
39
Figure 2.9
37174.07
18596.73
24000.4 43001.8
(m/z)
62003.2 81004.6 1000
1.11
(ft.O
Mass spectrometry of SC5 protein, showing a mass peak at 37174 within
experimental error of the expected mass of 37120.
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CHAPTER 3
MECHANICAL PROPERTIES OF CSS AND SC5 PROTEINS
3.1 Introduction and Obj ectives;
Bis(sulfosuccinimidyl)suberate and disuccinimidyl suberate were used to
crosslink CSS and SCS into films for uniaxial tensile testing. The mechanical properties
of the resultant films can were tuned by varying the amount of crosslinker and protein
weight fraction during crosslinking. The residual lysine content was measured
spectrophotometrically to quantify extent of crosslinking. The buffer content of the
hydrated, crosslinked films was measured and the theoretical molecular weight between
crosslinks (Mc) was determined. The modulus and Mc of the proteins were compared to
data reported for natural elastin.
3.2 Experimental Section
3.2.1 Measuring the LCST
The LCST of the protein was measured at 10, 20, 30 mg/ml concentrations in
phosphate buffered saline (PBS) pH 7.4 by increasing the temperature at a rate of 30
°C/hour and measuring the percent transmission at 300 nm on a CD spectrophotometer
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Model 62DS (Aviv, Lakewood, NJ). This was repeated twice for each concentration of
each protein with little or no variation in behavior.
3.2.2 Crosslinking Chemistry
The reaction scheme for crosslinking the protein is shown in Figure 3.1.
Bis(sulfo-succinimidyl) suberate (BS3) and disuccinimidyl suberate (DSS) are
commercially available bifunctional N-hydroxysuccinimidyl (NHS) esters (Pierce,
Rockford, IL). Both reagents were used without purification.
3.2.3 Film Casting
3.2.3.1 Method I
Method 1, shown in Figure 3.2, involved crosslinking a solution of protein, BS3,
and PBS between two glass plates with 0.45 mm plastic spacers at the edges to set the
gap height. Clamps held this assembly together until crosslinking was completed (see
Table 3.1). Films were made varying the stoichiometric ratio ofNHS to lysine at 0.5:1,
1 :1, and 1 .5:1
.
The protein was crosslinked at concentrations of 0.2 w/v and 0.4 w/v.
The crosslinking was done both above the LCST (at 25 °C) and below the LCST (at 4
°C).
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3.2.3.2 Method II
Method II is shown in Figure 3.3. A solution of protein (300 ^1 of 100 mg/ml
protein in dimethylsulfoxide (DMSO) (Sigma, St. Louis, MO)) was dried overnight at 50
°C in a teflon mold. The film was crosslinked by immersing it in a 5 ml solution of
disuccinimidyl suberate (DSS) (Pierce, Rockford, IL) in anhydrous dimethylformamide
(DMF) (Sigma, St. Louis, MO) at 5:1, 10:1, and 100:1 NHS to lysine stoichiometries.
3.2.4 Film Characterizatinn
3.2.4.1 Weight Fraction Protein
Buffer content of the films was defined by the difference in weight between dry
and wet samples. Wet samples were prepared by equilibration in PBS at 37 °C, followed
by the wicking away of excess water with filter paper. The films were then placed at 50
°C overnight in a vacuum oven before the dry weights were measured. Film weight was
measured again after 1 week at 50 °C under vacuum and showed no ftirther weight
reduction. The weight fraction protein was determined and the volume fraction
subsequently calculated using a protein density of 1.3 g/cm^ (equivalent to that of
collagen) [1] and a water density of 1 .0 g/cml
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3.2.4.2 Residual Lysine Content
Sulfo-succinimiciyl-4-0-(4,4'-dimethoxytrityl)-butyrate (SDTB) (Pierce,
Rockford, IL) was used to determine unreacted amines[2-5]. The reaction is shown in
Figure 3.4. Crosslinked films (1-5 mg) were immersed in 0.4 ml 50 mM NaHCOj pH
8.5, 1 mM SDTB and agitated for at least two hours at room temperature. Films were
removed from the solution, blotted with filter paper, immersed in 50 ml 50 mM NaHCOa
pH 8.5 and allowed to remain at 4 °C overnight. Films were removed from the buffer,
blotted with filter paper, and immersed in 1 ml 88 % formic acid. The films were agitated
1 hr at 25 °C and the resulting solution was diluted 1/100 in 88 % formic acid and the
absorbance at 498 nm was determined with a SpectraMax Plus 384 UV
spectrophotometer (Molecular Devices, Sunnyvale, CA).
A calibration curve was made using the uncrosslinked protein. The protein (3
mg) was dissolved in 0.4 ml 50 mM NaHCOa pH 8.5, 1 mM SDTB and agitated for at
least two hours at room temperature. The excess SDTB was removed by precipitating the
protein with 1 M NaCl, redispersing in 1 ml 50 mM NaHCOs and precipitating the
protein with 1 M NaCl five times. The resultant precipitated protein was dispersed in 1
ml 88 % formic acid. These solutions were diluted 1/100 in 88 % formic acid and the
absorbance at 498 nm was determined with a SpectraMax Plus 384 UV
spectrophotometer (Molecular Devices, Sunnyvale, CA).
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3.2.5 Tensile Testing
Protein films were measured with vernier calipers and a micrometer after
equilibration in PBS at 37 oc to determine cross-sectional area. The samples were tensile
tested under simulated physiological conditions (PBS, pH 7.4, 37 °C) on an Instron
Universal Testing Machine Model 5564. A schematic of the test apparatus is shown in
Figure 3.5. A uniform strain rate of 10 % gauge length per minute was used and the
aspect ratio of the samples was at least five, based on the ASTM Standard D 882-00. The
sample length was 12 ± 2 mm, width was 2 ± 1 mm and thickness 0.45 ± 0.1 mm.
3.3 Results and Discussion
3.3.1 LCST Behavior
Figure 3.6 and Figure 3.7 show the LCST behavior of the CS5 and SC5 proteins,
respectively at 10, 20, and 30 mg/ml concentrations. Both CS5 and SC5 show similar
LCST behavior. The onset of the transition occurs at 27 °C for the 10 mg/ml
concentration and increases to 28.3 °C and 29 °C for the 20 mg/ml and 30 mg/ml
solutions, respectively. The slope of the curve and maximum absorbance increases with
increasing concentration. Similar proteins without the lysine residues within the elastin-
like region have exhibited an LCST at 12 °C [6]. The addition of lysines at the N- and C^
termini increased the LCST to 17 °C [7]. The introduction of twelve lysines within the
protein for CS5 and SC5 raises the LCST to 27 °C. The increase in LCST is a result of
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the substitution of a more hydrophilic amino acid (lysine) for isoleucine and is consistent
with the prediction of Urry and coworkers [8].
3.3.2 NHS-ester Crosslinking
By taking advantage of the specificity of the reaction of NHS-esters with amines,
the crosslinking should occur only in the films through the lysine residues [9, 10]. The
most important competing reaction is likely to be hydrolysis of the ester by water,
especially when crosslinking is done in PBS. Amines in the lysines react very quickly
with the NHS-esters to produce insoluble films within minutes. The films are left to react
for at least 12 hr to ensure full crosslinking.
3.3.3 Film Characterization
3.3.3.1 Weight Fraction Protein
Table 3.1 gives the weight fraction protein in the crosslinked films. Films
prepared by Method I show a small increase in weight fraction protein with a decrease in
crosslinker stoichiometry when crosslinked at the same concentration (cf. Samples 1-3).
It is possible that the crosslinking restricts the film from excluding the water as it would
in a less crosslinked film. The films crosslinked with 0.2 w/v protein concentration have
a lower weight fraction protein (19.5 %) than those crosslinked at 0.4 w/v (28.7 %
protein). The protein concentration during crosslinking is the most significant factor
determining the final water content of the crosslinked film.
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For films prepared by Method II, the higher the crosslinker concentration, the
higher the weight fraction protein in the crosslinked film giving a range of 31.8 to 38.9
%. An increase in modulus is observed with an increase in weight fraction protein.
Purified, hydrated elastin is known to contain approximately 65 % protein [11].
Although this protein content is higher than the described films, the moduli of the films
are in the same range.
3.3.3.2 Residual Lysine Content
Table 3.1 shows the percentage of reacted lysines in the films. Sample 1 shows
42 % of the lysines reacted which is approximately half of that of Sample 2. This
change in the extent of reacfion is consistent with the use of half the crosslinker needed to
crosslink the sample. Adding 50 percent excess crosslinker as in Sample 3 does not
significantly increase the number of reacted lysines. Sample 5 shows 61 % of the lysines
reacted, lower than that of Sample 2 because at lower concentrations, hydrolysis would
compete more strongly. The temperature of reaction does not affect the percentage of
reacted lysines in the films (cf. Samples 4, 2). Samples 6-8 show 90 % reacted lysines
as would be expected with the presence of excess crosslinker.
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3.3.4 Mechanical Properties of FilmQ
3.3.4.1 Treatment of Mechanical Testing Data
The mechanical properties of the different films are tabulated in Table 3.2. The
statistical treatment of rubber elasticity provides a relationship between stress (a) and
elongation ratio (X) of random network materials for strains below 50 %:
where G is the shear modulus [11-13]. The Young's modulus (E) is related to the shear
modulus by the formula
E - 2(1 + v)G, (2)
where v is Poisson's ratio. When the material is a volumetrically incompressible rubber
V = '/2 and Equation 2 becomes E = 30 [13, 14]. E can be determined from the initial
linear region of the stress-strain curve (strains < 5 %) and can be compared through the
above relationship to G.
For rubbery materials, theory states that G is inversely proportional to the
molecular weight between crosslinks (Mc) through the relationship
G= pRT/Mc, (3)
where p is the protein concentration in g/cm^ R is the gas constant, and T, the
temperature[l 1-14]. Equation 3 assumes the network is perfect, in that all chains are
effective in giving rise to elastic stress and each crosslink connects four network chains.
Equation 3 should hold for samples crosslinked in solution.
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3-3.4.2 Mechanical Properties of Method T FilmQ
3-3.4.2.1 Variation ofNHS to T vdng Stoichiometrv
Figure 3.8 and Figure 3.9 show the stress-strain behavior of CSS and SC5 films
crosslinked using Method I in PBS at 25 °C with NHS/lysine stoichiometrics of 0.5:1,
1:1, and 1.5:1. Figure 3.10 shows the determination of G, and Figure 3.11 shows the
determination of E. The tensile modulus is indeed one third of the shear modulus
agreeing well with theory and yielding tensile moduli ranging from 0.07 to 0.19 MPa. As
might be expected, the 0.5:1 stoichiometric amount of crosslinker yields a modulus less
than half of the modulus for the 1.0:1.0 stoichiometry. Increasing the amount of
crosslinker to 1.5:1 stoichiometry does not significantly change the modulus of the film
from the 1 :1 stoichiometry. Although this higher crosslinker concentration could be
expected to decrease the modulus by increasing tethered ends and reducing the number of
effective crosslinks in the sample, it remains unchanged. Competing hydrolysis and
incomplete reaction could negate this effect.
3.3.4.2.2 Variation of Crosslinking Time
The effect of crosslinking time on the mechanical properties was explored by
allowing the films to crosslink for 12, 24, and 48 hr. Figure 3.12 shows the stress-strain
curves for CS5 protein films illustrating no difference in the mechanical properties with
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an increase in reaction time. This ensures the reaction was complete for each of the
studies since the films were allowed at least a 12 hr reaction time.
3.3.4.2.3 Variation of Protein Concentr^^fi^n
Figures 3.13 and 3.14 show the tensile properties of CSS and SC5 protein films
cast at both 0.2 and 0.4 w/v protein in PBS at 25 °C. For both proteins, the modulus for
the 0.4 w/v sample is approximately twice that for the 0.2 w/v sample. From Equation 3,
since the modulus is proportional to the chain density, a sample with twice the chain
density and other properties remaining the same would have twice the modulus.
3-3.4.2.4 Variation of Crosslink ing Temperature
In aqueous solution (PBS) the protein exhibits an LCST as mentioned previously.
At the high concentration of 0.4 w/v the LCST is very close to 25 °C and as the lysines
are neutralized by reaction, the LCST is lowered further. A film crosslinked at 25 °C is
considered reacted above the LCST. All of the previously described films were
crosslinked above the LCST (at 25 °C); as a result of this, the fomiation of the coacervate
gives the film a completely opaque, white appearance. Conversely, protein films
crosslinked below the LCST at 4 °C remain clear, and after crossl inking do not appear to
go through the LCST even upon raising the temperature of the film, l-igurc 3.15 shows
two films clamped in a testing grip, illustrating difference in appearance between films
crosslinked above the LCST (25 °C) and films crosslinked below the LCST (4 °C).
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Figure 3.16 and Figure 3.17 show SEM micrographs of films crosslinked above
and below the LCST, respectively. The films crosslinked above the LCST show a very
rough, inhomogeneous, aggregated morphology. In contrast, the sample reacted below
the LCST has a smooth, homogeneous texture.
Figure 3.18 and Figure 3.19 show the tensile behavior of CSS and SC5 protein
films crosslinked above and below the LCST. Although the morphologies of the sample
are very differem, the modulus is unaffected when measured under these conditions.
This might bring to question the role of secondary structure in affecting bulk mechanical
behavior. It is possible, although the films remain clear, that the protein has undergone
the conformational change, but appear the same since aggregation, which causes the
opacity, is restricted by crosslinks. Although the films respond similarly when tested
under simple uniaxial tension, there may be differences in other mechanical properties
such as tear resistance and hysteresis that result from the morphological disparity.
3.3.4.2.5 Variation of Testing Temperature
Elastin swelling involves changes in hydrophobic interactions, and these swelling
changes create a material whose mechanical properties are nearly temperature
independent. While this temperature independence is not important in higher vertebrates
that can maintain constant body temperature, in fishes where it evolved, elastin had to
efficiently store elastic energy at temperatures as low as -2 °C. It is therefore suggested
that elastin evolved as a design feature to produce a temperature-independent rubber-like
materia! [15].
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The mechanical properties of the films were tested at temperatures varying from 4
°C to 45 °C. The stress-strain behavior of the 0.2 w/v and 0.4 v./v films at these
temperatures is shown in Figure 3.20 and Figure 3.21, respectively. Similar to the
response of natural elastin samples, the films do not show temperature dependent
mechanical behavior.
3-3.4.3 Mechanical Properties of Method IT Film^
It is desired to mimic the properties of naturally occurring elastin which has a
modulus in the range of 0.3-0.6 MPa [11, 14, 16]. Therefore the next set of films were
made using Method II in an effort to increase the chain density and subsequently the
modulus of the materials. The crosslinker concentrafions were varied from 100:1 to 5:1
NHS/lysine stoichiometry. Figure 3.22 shows the mechanical behavior of these
crosslinked films. As the concentrafion of crosslinker is increased, the modulus also
increases, giving a range of 0.35 - 0.97 MPa, which lies close to or within the desired
range of moduli.
3.3.5 Theoretical Mc
Using Equation 3, the theoretical Mc was determined. The Mc for the crosslinked
films is shown in Table 3.1
.
For Method I, Sample 1 has a lower modulus than Sample 2
or 3, and a similar protein weight fraction. This would be expected from a lower amount
of crosslinker and is indicative of an increase in Mc (as can be calculated from Equation
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3). Although the moduH of Sample 1 and Sample 5 are similar, the values ofMo are
20,000 g/mol and 38,000 g/mol respectively. The higher Mc for Sample 5 (a resuh of
low amount of crosslinker) leads to a lower modulus, whereas the lower weight fraction
protein (a result of a lower concentration during crosslinking) does not affect the Mc. and
also leads to a low modulus. Tl,e lower weight fraction protein compensates for the lower
crosslinker concentration in the modulus difference in Mc, allowing similar moduli.
For Method II films, the theoretical Mc ranges from 7000 g/mol to 3000 g/mol
with increasing crosslinker concentration. This encompasses the Mc for elastin, which is
6000-7000 g/moI [11, 17]. Although the modulus and Mc are similar in these films, the
water content is much higher.
The expected Mc for the proteins is 2500 g/mol assuming all crosslinks are
effective and there are no chain ends. The Mc for the most highly crosslinked samples
(Method II, 100:1 stoichiometry) is very close to the expected at 3000 g/mol.
3.4 Summary and Conclusion^;
The films prepared in this work yielded Young's moduli ranging from 0.07 MPa
to 0.97 MPa. The residual lysine content quantified the extent of crosslinking to be
between 42 % and 89 % depending on crosslinking conditions. The buffer content of the
crosslinked films was between 19.5 % and 38.9 % and the theoretical molecular weight
between crosslinks (Mc) was determined to vary from 38000 g/mol to 3000 g/mol. The
modulus and Mc of the proteins are in the same range as is reported for natural elastin.
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The crossHnked proteins show interesting and promising mechanical properties
for the application of a vascular graft. By changing the method and conditions of
crosslinking, the moduli and Mc can be controlled within the range expected for native
elastin. The theoretical Mc is very close to what would be expected for an ideally
crosslinked network of the proteins. The CSS and SC5 proteins show no difference in
mechanical properties indicating the scrambling of the cell-binding domain does not
affect the mechanical properties.
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NHS/Lysine
Stoichiometry
Protein Solution
Conc.(w/v)
Reaction
Temp. (C)
Method I: Films crosslinked in PBS with BS3
CSS
1
2
3
4
5
SC5
6
7
8
9
10
0.5
1
1.5
1
1
0.5
1
1.5
1
1
0.4
0.4
0.4
0.4
0.2
0.4
0.4
0.4
0.4
0.2
Meihod II: Films immersed in DMF/DSS crosslinking solution
CS5
11
12
13
Eiastin
5 :
10
100
dry film
dry film
dry film
Reaction
Time (hr)
Wt. Fraction
Protein (w/w)
Reacted
Lysines(%
^ In films equilibrated at 37 ^C.
^Reference [11].
Table 3.1 Physical properties of crosslinked CS5 and SC5 protein films
Mc xlOOO
(g/mol)
0.30 + 0.03 42+7 38
25 >12 0.29 + 0.02 75+7 14
25 >12 0.25 + 0.03 76+8 11
4 >12 0.32 + 0.02 74+7 15
25 >12 0.20 + 0.02 61 + 15 20
25 >12
25 >12
25 >12
4 >12
25 >12
25 >24 0.32 7
25 >24 0.37 + 0.01 4
25 >24 0.39 + 0.02 90+7 3
6"
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Sample # Samples Tensile Modulus
tested E (MPa;
Method I: Films crosslinked in PBS with BS3
Shear Modulus
G (MPa
CSS Protein
1 5
2 8
3 5
4 6
5 5
SC5 Protein
6 3
7 5
8 2
9 3
10 2
0.07 + 0.03 0.022 + 0.003
0.17 + 0.01 0.055 + 0.001
0.19 + 0.01 0.060 + 0.001
0.18 + 0.02 0.060 + 0.002
0.08 + 0.01 0.026 + 0.001
0.05 + 0.02
0.15 + 0.02
0.16 + 0.02
0.17 + 0.03
0.08 + 0.02
0.015 + 0.001
0.052 + 0.005
0.055 + 0.005
0.058 + 0.002
0.035 + 0.003
Method II: Films immersed in DMF/DSS crosslinking solution
CS5 Protein
11 4
12 6
13 5
0.35+ 0.31
0.77+ 0.12
0.97 + 0.31
0.12+ 0.08
0.25+ 0.05
0.32 + 0.10
Elastin^ 0.30 - 0.60
Reference [11, 14, 16].
Table 3.2 Mechanical properties of crosslinked CSS and SC5 protein films.
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Figure 3 .
1
Reaction scheme for crosslinking the lysine residues of the protein with
bifunctional NHS esters. R' is (CH2)6, for DSS, R-H; for BS3 R^SO,"
Na
.
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Crosslinked Film
Figure 3.2 Film casting by Method I.
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Protein dried down
Immerse in crosslinking
solution: DSS in DMF
Crosslink and transfer
to PBS for testing
Figure 3.3 Film casting by Method II.
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OCH.
Amine Containing
Protein
OCH,
0-(CH,)3-_JLoH^ pH > 7
OCH
Sulfo-succinimidyl-4-0-(4,4'-ciimethoxytrityl)butyrat(
(Sulfo-SDTB)
// w O (CH^);
Formic Acid
1HC^CH2)3--^
H
OCH
Figure 3.4
QCH
OCH
Reactio of Sulfo-SDTB for detection of residual lysines in crosslinked
films by measuring absorbance at 498 nm of the dimethoxytrityl cation
product.
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gure 3.5 Tensile testing apparatus allowing uniaxial tensile tests under
simulated physiological conditions (37 °C, PBS pH 7.4).
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Figure 3.6 LCST behavior of CSS protein at 10, 20, and 30 mg/ml concentrations.
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gure 3.7 LCST behavior of SC5 protein at 10, 20, and 30 mg/ml concentrations.
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0.14-1
Strain (%)
gure 3.8 Stress-strain behavior of CSS protein films crosslinked by Method I
0.5:1, 1:1, and 1.5:1 NHS to lysine stoichiometries.
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strain (%)
Figure 3.9 Stress-strain behavior of SC5 protein films crosslinked by Method I
0.5:1, 1:1, and 1.5:1 NHS to lysine stoichiometries.
66
Figure 3.10 Determination of shear modulus, G, of CSS protein films by measuring the
slope of the line formed by plotting stress vs. X-MX^.
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strain (%)
gure 3.11 Determination of tensile or Young's modulus, E, of CSS protein films by
measurmg the slope of the line formed by plotting stress vs. strain for the
first 5 % strain.
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0.08
Strain (%)
gure 3.12 Stress-strain behavior of CSS protein films crosslinked by Method 1 for
12, 24, and 48 hr.
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0.08-
Strain (%)
gure 3.13 Stress-strain behavior of CSS protein films crosslinked by Method 1 at
w/v and 0.4 w/v concentrations.
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0.05
Strain (%)
gure 3.14 Stress-strain behavior of SC5 protein films crosslinked by Method I at 0.2
w/v and 0.4 w/v concentrations.
71
Figure 3.15 Two films clamped in an Instron testing grip, exhibiting difference in
appearance between (a) films crosslinked above the LCST (25 °C) and
(b) films crosslinked below the LCST (4 °C)
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Figure 3.16 SEM micrographs of a CSS film crosslinked by Method I above the
LCST (25 °C).
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gure 3.17 SEM micrographs of a CSS film crosslinked by Method I below the
LCST (4 °C).
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0.12-1
Strain (%)
Figure 3.18 Stress-strain behavior of CSS protein films crosslinked by Method I at
4 °C and 25 °C.
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gure 3.19 Stress-strain behavior of SC5 protein films crosslinked by Method I at
4 °C and 25 °C.
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Figure 3.20 Stress-strain behavior of a 0.2 w/v crosslinked CS5 protein film tested at
15,25, 37, and 45 °C.
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Figure 3.21 Stress-strain behavior of a 0.4 w/v crosslinked CSS protein film tested at
15,25, 37, and 45 °C.
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ure 3.22 Stress-strain behavior of films crosslinked by Method II in solutions with
100:1, 10:1 and 5:1 NHS to lysine stoichiometries.
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CHAPTER 4
MECHANICAL PROPERTIES OF CSl PROTEIN
4.1 Introduction and Obj ectives
Mechanical properties of the CSl protein were explored to determine the potential
for use as a vascular graft material. Bis(sulfosuccinimidyl)suberate was used to crosslink
the protein into films for uniaxial tensile testing. The amount of crosslinker, protein
weight fraction, and method of crosslinking were varied to yield differing mechanical
properties. The residual lysine content was measured spectrophotometrically to quantify
extent of crosslinking. The buffer content of the crosslinked films was measured and the
theoretical molecular weight between crosslinks (Mc) was determined.
4.2 Experimental Section
4.2.1 Measuring the LCST
See secfion 3.2.1
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4.2.2 Film Casting
4.2.2.1 Method I
See Section 3.2.3.1, except above the LCST refers to 37 °C instead of 25 °C.
4.2.2.2 Method III
Method III, shown in Figure 4.1, involved crosslinking a 0.1, 0.2, or 0.3 w/v
solution of protein in PBS with a 1 :1 NHS/lysine ratio using bis(sulfo-succinimidyl)
suberate (BS3) (Pierce, Rockford, IL) in a teflon mold. The solution was spun at 2000 g
for 2 min on a plate spinner to create a flat film. This was then placed on a 60 °C
hotplate overnight. Films were rehydrated in cold PBS for at least 2 hrs prior to bringing
them to 37 °C for testing.
4.2.3 Film Characterization
4.2.3.1 Weight Fraction Protein
See Section 3.2.4.1.
I
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4-2.3.2 Residual Lysine Content
See Section 3.2.4.2.
4.2.4 Tensile Testing
See Section 3.2.5.
4.3 Results and Discussion
4.3.1 LCST Behavior
Figure 4.2 shows the LCST behavior of the protein at 10, 20, and 30 mg/ml
concentrations. The onset of the transition occurs between 36 °C and 37 °C for each of
the concentrations with the slope of the curve increases with increasing concentration.
The CSl has an LCST 10 °C higher than CS5 and SC5.
4.3.2 Film Characterization
4.3.2.1 Weight Fraction Protein
Table 4.1 gives the weight fraction protein in the crosslinked films. In general,
the CSl films behaved similarly to the CSS films. However, there is no difference in
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weight fraction protein with a decrease in crossHnker in Samples 1-3. This indicates the
trend seen previously is likely within error of the measurement. Like the CSS, the CSl
films increase in weight fraction protein with an increase in crosslinking solution
concentration (cf Samples 2, 5). As was seen with the CSS films, the protein
concentration during crosslinking is the most significant factor determining the final
water content of the crosslinked film.
For films prepared by Method III, the higher the concentration during
crosslinking, the higher the weight fraction protein in the crosslinked film giving a range
of 25 to 32 %. In agreement with equation 3, an increase in modulus is observed with an
increase in weight fraction protein.
4.3.2.2 Residual Lysine Content
Table 4.1 shows the percentage of lysines reacted in the films. Again, CSl shows
similar levels of reacted lysines as the CSS films although the values for Method I films
are slightly higher and the values for Method III films are slightly lower. Sample 1
shows 46 % of the lysines reacted which is approximately half of that of Sample 2. As
with the CSS results, this extent of reaction is consistent with the use of half the
crosslinker needed to crosslink the sample. Adding 50 percent excess crosslinker as in
Sample 3 does not significantly increase the number of reacted lysines. Sample 5 shows
76 % of the lysines reacted, lower than that of Sample 2, because at lower concentrations
hydrolysis would compete more strongly. The temperature of reaction does not affect the
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percentage of reacted lysines in *e films (cf. Samples 4, 2). Samples 6 - 8 show 85 %
reacted lysines, which seems lower than would be expected with the presence of excess
crosslinker.
4-3.3 Mechanical Properties of Film^
4-3.3.1 Treatment of Mechanical Testing Data
See Section 3.3.4.1.
4.3.3.2 Mechanical Properties of Method 1 Filtn«;
4-3.3.2.1 Variation ofNHS to Lysine Stoichiometrv
Figure 4.3 shows the stress-strain behavior of films crosslinked using Method I in
PBS at 37 °C with BS3/lysine stoichiometrics of 0.5:1, 1:1, and 1.5:1. Figure 4.4 shows
the determination of G, and Figure 4.5 shows the determination of E. The tensile
modulus is again one third of the shear modulus agreeing with theory and yielding tensile
moduli ranging from 0.06 to 0.17 MPa. The moduli are within error of moduli for the
CS5 films crosslinked by the same process. The modulus of Sample 1 is less than half of
the modulus for Sample 2, and increasing the crosslinker amount (Sample 3) does not
significantly change the modulus from Sample 2. This was previously described in
Chapter 3 for CS5 films and similarly, although the high amount of crosslinker might be
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expected to decrease the modulus by increasing tethered ends and reducing the number of
effective crosslinl<s, it seems this effect is not signiHcant. As with the CSS it is possible
competing hydrolysis and/or incomplete reaction negate this effect. Since a 1:1 ratio
should fttlly crosslink the sample under ideal crosslinlcing, the fact that an increase in
crosslinker does not significamly increase the modulus indicates fairly efficient
crosslinking.
4.3.3.2.2 Variation of Crosslinking Timp
The effect of crosslinking time on the mechanical properties was explored by
allowing the films to crosslink for 12, 24, and 48 hr. Figure 4.6 shows the stress-strain
curves illustrating no difference in the mechanical properties with increasing reaction
time. This ensures the reaction was complete for each of the studies since the films were
allowed at least a 12 hr reaction time.
4.3.3.2.3 Variation of Protein Concentration
Figure 4.7 shows the tensile properties of films cast at both 0.2 and 0.4 w/v
protein in PBS at 37 °C. As with the CSS films, the modulus for the 0.4 w/v sample is
approximately twice that for the 0.2 w/v sample. From Equation 3, since the modulus is
proportional to the chain density, a sample with twice the chain density and other
properties remaining the same would have twice the modulus.
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^•3-3.2.4 Variation of Crosslinking Temperature
In aqueous solution (PBS) the protein exhibits an LCST as mentioned previously.
For the CSl protein, at 0.4 w/v the LCST is below 37 °C, and as the lysines are
neutralized by crosslinking, the LCST is lowered further. The previously described films
were crosslinked above the LCST (at 37 °C) where the films have a completely opaque,
white appearance. Conversely, protein films crosslinked below the LCST (at 4 °C), after
crosslinking do not appear to go through the LCST and remain clear, even after raising
the temperature. Figure 4.8 shows the tensile behavior of films crosslinked above (37
°C) and below the LCST (4 °C). As with the CS5 films, although the appearance of the
samples is very different, the modulus is unaffected. Again, it is possible that tests other
than uniaxial tensile tests could elucidate some mechanical differences not shown with
this test.
4.3.3.3 Mechanical Properties of Method III Films
Naturally occurring elastin has a modulus in the range of 0.3-0.6MPa [1-3].
Prepared films by Method II encompass this range, but had a higher than desired standard
deviation (see Table 3.2). Therefore the next set of films were made using Method III to
improve the film quality and maintain the appropriate modulus. Figure 4.9 shows the
mechanical behavior of these films crosslinked at 0.1, 0.2, and 0.3 w/v protein. As the
concentration of protein is increased, the modulus also increases, giving a range of 0.21-
0.58 MPa, which lies close to or within the desired range of moduli.
88
4.3.4 Theoretical Mc
Using Equation 3, the theoretical Mc was determined. The Mc for the crosslinked
films is shown in Table 4. 1
.
As is seen with the CS5 protein, for Method I, Sample 1 has
a lower modulus than Sample 2 and 3 and a similar protein weight fraction. This is a
result of a larger Mc as can be calculated from Equation 3. Although the moduli of
Samples
1 and 5 are similar, Mc is 35,000 g/mol and 22,000 g/mol respectively. Similar
to the CSS films, the lower weight fraction protein compensates for this difference in Mc,
allowing similar moduli.
For films prepared by Method III, the theoretical Mc ranges from 10000 g/mol to
3000 g/mol with increasing protein concentration. This encompasses the Mc for elastin
of 6000-7000 g/mol as well as the known modulus [3, 4]. Although the modulus and Mc
are similar in these films, the water content is much higher.
The expected Mc for the proteins is 2500 g/mol assuming all crosslinks are
effecdve and there are no chain ends. The Mc for the highest crosslinked samples
(Sample 8) is very close to the expected at 3000 g/mol.
4.4 Summary and Conclusions
By varying amount of crosslinker, protein weight fraction, and method of
crosslinking, CSl films yielded Young's moduli ranging from 0.07 MPa to 0.58 MPa.
The residual lysine content was measured spectrophotometrically to quantify the extent
of crosslinking to be between 46 % and 85 %. The buffer content of the crosslinked films
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was measured and the theoretical molecular weight between crosslinks (Mc) was
detennined to vary from 35000 g/mol to 3000 g/mol. The Mc is very close to what would
be expected for an ideally crosslinked network of the protein. The mechanical properties
of the CSl films are within error of the CSS and SC5 films (cf. Chapter 3-Sample 1-10,
Chapter 4 - Samples 1-5). The modulus and Mc of the CSl protem films prepared by
Method III are in the same range as is reported for natural elastin.
The crosslinked proteins show interesting and promising mechanical properties
for application in vascular grafts. By changing the method and conditions of
crosslinking, the moduli and Mc can be controlled within the range expected for native
elastin. The Mc is very close to what would be expected for an ideally crosslinked
network of the protein. The CSl compared to the CSS and SC5 proteins show no
significant difference in mechanical properties indicating the differing cell-binding
domain does not affect the mechanical properties. Although not surprising, it is
important information for the future incorporation of alternative cell-binding domains.
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bample NHS/Lysine
Stoichiometry
Protein Solution
Conc.(w/v)
Method
1
2
3
4
5
Method
6
7
8
Films crosslinked in PBS with BS3
0.5:1.0 04
1.0:1.0 04
1.5:1.0 0.4
1.0:1.0 0.4
1.0:1.0 0^2
Films spun flat and dried
1.0:1.0
1.0:1.0
1.0:1.0
Elastin
0.1
0.2
0.3
Reaction
Temp. (C)
37
37
37
4
37
60
60
60
Reaction
Time (hr)
Wt. Fraction
Protein (%)
Mc xlOOO
(g/mol)
6"
Reacted
Lysines(%)
>12 0.28 + 0.05 35 6 + 8
>1? 15 83 + 7
>12 0.28 + 0.02 13 81+8
>12 0.28 + 0.05 13 83 + 7
>12 0.22 + 0.03 22 86 + 15
>12 0.25 + 0.02 10 84 + 6
>12 0.27 + 0.04 5 83 + 5
>12 0.32 + 0.03 3 85 + 7
Reference [3].
Table 4.1 Physical properties of crosslinked CSl protein films.
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Sample
#
# Sample Tensile Modulus
Determinants E (MPa
Films Crosslinked by Method
1
2
3
4
5
Films Crosslinked by Method
6 3
7 4
8 3
Native Elastin
' Reference [1-3]
Table 4.2
0.21 + 0.06
0.41 + 0.05
0.58 + 0.07
0.30 - 0.60^
Shear Modulus
G(MPa
3 0.06 + 0,02 0.027 + 0.003
5 0.16 + 0.01 0.052 + 0.001
4 0.17 + 0.03 0.058 + 0.001
4 0.16 + 0.01 0.056 + 0.002
3 0.07 + 0.01 0.027 + 0.002
0.07 + 0.008
0.14+ 0.005
0.28 + 0.004
Mechanical properties of crosslinked CSl protein films.
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Add crosslinking
i Solution to mold
Heat 60 °C
i to remove solvent
Figure 4. 1 Film casting by Method III.
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igure 4.2 LCST behavior of the CSl protein at 10, 20, and 30 mg/ml concentrations.
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0.12-
Strain (%)
Figure 4.3 Stress-strain behavior of CSl protein films crosslinked by Method I
0.5:1, 1:1, and 1.5:1 NHS to lysine stoichiometrics.
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Figure 4.5 Determination of the tensile or Young's modulus, of crosslinked CSl
films.
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gure 4.6 Stress-strain behavior of CS 1 protein films crosslinked by Method I for
12, 24, and 48 hr.
98
0.10
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Figure 4.7 Stress-strain behavior of CS 1 protein films crosslinked by Method I at
w/v and 0.4 w/v concentrations.
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0.08-
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Figure 4.8 Stress-strain behavior of CSl protein films crosslinked by Method I at
4 °C and 37 °C.
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gure 4.9 Stress-strain behavior of CS 1 protein films crosslinked by Method III
0. 1 , 0.2, and 0.3 w/v protein concentrations.
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CHAPTER 5
THIOLATION OF CSS PROTEIN FOR DISULFIDE CROSSLINKING
5.1 Introduction and Obj ective<;
By thiolating the lysines in CSS, the effect of disulfide crosslinking on the
mechanical properties can be investigated. Disulfide bonding is a mechanism of
crosslinking and stabilization found in native proteins [1]. A disulfide group is relatively
unreactive and stable under the physiological conditions experienced by the ECM. This
stability is the general basis of its biochemical function, maintaining protein structure.
Proteins containing disulfide bonds are thus sufficiently stable to be found in the ECM.
Many important proteins contain cysteines that function in both intra- and inter-molecular
disulfide bonding [2].
By modifying the lysines to thiols after the protein is expressed and purified, the
complication of purifying a cysteine rich protein is eliminated. Initially the intended
design of this thesis involved incorporation of cysteine in the place of the lysines in the
CSS. This strategy proved to be very difficult to implement. The protein was never
successfully purified and the lysine motif was adopted as an alternative. Once the lysine
is modified to a thiol, it can be disulfide bonded or reacted with maleimide derivatives for
further modification. The modification reagent of choice is N-succinimidyl S-
acetylthioacetate (SATA). The protected thiol moiety allows processing and deprotection
without thiol reductants such as p-mercaptoethanol or dithiothreitol [3].
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5.2 Experimental Section
5.2.1 Protein Thiolation
The CSS protein (100 mg) was placed in a 4 ml vial with a small stir bar and dried
overnight at 50 °C in a vacuum oven. The oven was purged with nitrogen and the vial
quickly capped. Anhydrous DMSO (2 ml) was added to the vial to dissolve the protein.
Approximately a five fold excess of the modifying reagent N-succinimidyl S-
acetylthioacetate (SATA) (50mg) was dissolved in 1 ml anhydrous DMSO and added to
the protein solution. This was stirred overnight to produce a yellowish solution. The
solution was added drop-wise to 4 °C H2O while stirring. The resulting solution was
dialyzed against 4 °C H2O for six, 4-liter H2O changes. The dialyzed solution was
centriftiged (1 hr, 4 °C, 30000g), and the supernatant frozen and finally lyophilized. The
reaction scheme for the SATA modification is shown in Figure 5.1 and the modified
protein is designated CS5-SATA.
5.2.2 NMR ofThiolated Protein
NMR spectra of the CS5, and CS5-SATA proteins were taken on a Varian Inova
600 MHz NMR Spectrometer in deuterated DMSO at 25 mg/ml.
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5.2.3 Measuring the l.CST
See Seclion 3.2.1.
5.2.4 l-ilm Caslinp
Films were cast u,sing Mclhc-d IV as sh<,wn in I'igure 5.2. Pmtein (45 mg) was
dissolved in UMHO at 3()() n,g/,„l and pu. into a tellon mold. I he film was dried
overnigl,, a, 60 C. Tl,e dried lilm was immersed in 10 ml of 25 C deacelylalion solution
(50 mM sodium phosphate, 25 mM 1.:DTA. 0.5 M hydroxylan.ine 1 ICl, pi 1 7.5) and
mildly agitated for 12 hr. The (Ihn was transferred lo 20 ml eold 1-HS twiee for 1 hr to
rinse the II Im.
5.2.5 Film Chaiacteii/ation
5.2.5.1 Reduction ol" Disulfides
The disullkle crosslinked lilni (20 nig) was immersed in 10 ml 4 M urea and 10%
p-mereaploethanol for 5 min at 25 °C.
5.2.5.2 Weitzht I'raetion Protein
See Section 3.3.4.1
.
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5.2.5.3 Residual Lysine Content
See Section 3.3.3.2.
5.2.6 Mechanical Testing
See Section 3.2.5.
5.3 Results and Discussion
5.3.1 Protein Thiolation
The protein was reacted with SATA to produce a protected thiol. This allowed
processing of the protein into films or tubes prior to disulfide bonding. Once the
processing was complete, the thiol could be deacetylated to liberate the free thiol and
allow disulfide bonding to occur spontaneously.
5.3.2 NMR Analysis of Thiolated Protein
The NMR spectra of SATA, CS5, and CS5-SATA arc shown in Mgure 5.3. By
using the known shifts for isoleucine in this type ol" protein [4J and the fact that there are
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54 isolcucincs to each lysine, it ean be determined that the CSS is approximately 50 - 60
% modilled under the conditions used here.
5.3.3 LCST Behavior
Modification ofthe protein drastically changes the concentration dependent
behavior of the LCST. The IX^ST behavior ol SATA-CSS is shown ni l .gurc 5.5. The
LCST of the 10 mg/ml CS5-SATA is similar to the LCST oi the 10 nig/ml CS5 showing
an onset at 27 °C. The onset ofthe LCST drops t(, 20 °C and 7 °C as the concentration of
the CS5-SA l A is increased to 20 mg/ml and 30 mg/ml, respectively, fhis is very
diflerent than the LCST ofthe CS5 that only varies down to 26 °C with the same increase
in concentration. It is possible the stability of the protecting group is compromised under
these conditions and disulfide bonding occurs, an effect that is enhanced with increasing
concentration. I his is supported by the Tact that the protein becomes increasingly
difficult to rinse from the (est cell without a denaturant and reducing agent.
5.3.4 Film Casting
The modilled protein disst)lves readily in DMSO to form a thick, amber solution
1 he film dries clear and remains clear alter immersion in the 25 °C deacetylation
solution. This indicates disulfides form spontaneously alter deacetylation since the
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protein does not appear to go through an LCST after immersion. If the film is not
completely dry of the DMSO, the disulfides do not seem to form immediately, or the
concentration is not high enough, and the film turns opaque.
5.3.5 Film Characterization
5.3.5.1 Reducfion of DisiilfiHeQ
When immersed in a solution of 4 M urea or DMSO, the disulfide crosslinked
films remain stable, swelling relative to the solvent as would be expected of a crosslinked
matrix. If the film is immersed in a solution of 4 M urea and 10 % P-mercaptoethanol it
completely dissolves within minutes.
5.3.5.2 Weight Fraction Protein
The protein weight fraction in the hydrated films is 33 % and is shown in Table
5.1. This is similar to the weight fraction protein in the higher crosslinked CS5 films.
5.3.5.3 Residual Lysine Content
The percentage of reacted lysines is shown in Table 5.1 . Approximately 90 % of
the lysines are reacted with SATA. This assay is not consistent with the NMR data,
which showed 50 - 60 % reaction with the SATA.
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^•^•6 Mechanical Properties and l-h^nr^tjo^i
us was
The mechanical properties of the CS5-SATA films are tabulated in Table 5.2.
Treatment of the mechanical data is described in Section 3.3.4.1.
The stress-strain behavior of a disulfide crosslinked film is shown in Figure 5.7.
Figure 5.8 shows the determination of G, and Figure 5.9 shows the determination of E.
The tensile modulus is indeed one third of the shear modulus agreeing well with theory
and yielding an average tensile modulus of 0.46 MPa. Films made from the thiolated
protein have a Young's modulus that lies within the range reported for native elastin and
in the higher range given for cro.sslinked CS5 protein films. The shear modul
determined using up to 25 % strain since the curve of the stress vs. X-\IX^ became
nonlinear at higher strains.
The shape of the stress-strain curve is typical of nonlinear viscoelastic behavior of
reinforced nonhomogeneous elastomers. The Payne effect describes a strain-dependent
contribution to the modulus based on an agglomeration-deagglomeration mechanism
between aggregates within a filler network [5]; at high strain amplitude, the stress
plateaus, or there is a decrease in modulus. Since the films are completely clear and
homogeneous in appearance, this may indicate an effect from disulfide exchange.
The Mc for the crosslinked thiolated protein is 6000 g/mol, which is similar to
that reported for natural elastin, and the results for the CS5 films crosslinked by Method
11.
I
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5.4 Conclusions and Summary
Disulfide crosslinking of thiolated protein produces coherent, stable films.
Mechanical testing of the films yields moduli and Mc in the range reported for native
elastin. The NMR analysis shows 50 - 60 % thiolation and a Mc of 6000 g/mol. This Mc
agrees with a 50-60 % modification since the Mc would be 2500 for a film with 100 %
modification and crosslinking. The shape of the stress-strain curve is unusual for a
homogeneous material, indicating possible effects of disulfide exchange.
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Sample
SATA Modified
Protein
Elastin
' Reference [6]
Deacetylation Wt. Fraction
Time Protein
Mc xlOOO
i/mol'
NMR-Reacted SDTB-Reacted
Lysines(%) Lysines(%)
12 hr 32.5 + 4.3 50-60 90.9 + 2.5
6-7'
Table 5.1 Physical properties of disulfide crosslinked CS5-SATA protein films
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bample # Sample ' Tensile Modulus Shear Modulus
Determina nts E (MPa^ r^ryiD^\
SATA Modified ^J^!}^^ G(MPa]
0.15 + 0.01
Protein 3 0.46 ± 0.03
Elastin 0.30-0.60^
^ Reference [6-8].
Table 5.2 Mechanical properties of disulfide crosslinked CS5-SATA protein lllms,
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STEP 1
:
Reaction of SATA with primary amines
° O
R-NH2 +
,0
^ 0 pH>7
O SATA
(N-Succinimidyl S-Acetylthioacetate
)
R-N
I
H
STEP 2:^Deacetylation of protecting group to liberate free thiol
NH2OHR-N
O
Hydroxyl amine
pH >7
R-N
1
H
STEP 3: Spontaneous formation of disulfide crosslinked matrix
SH
s—s—
o
HOHN
ure 5.1 SATA-modification reaction scheme for the thiolation of CSS protein,
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Modified Protein film dried from DMSO
Immerse in deacetylation solution
Allow to crosslink and transfer to PBS
for testing
Figure 5.2 Film casting by Method IV
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(2)
(3)
(1)
A
HoO
1.00
DMSO
1.29
4.4 4.2
2.06
4.0 3.8 3.6 3.4 3.2 3.0 2.8 2.6 2.4
Figure 5. 3 NMR spectrum of SATA.
J
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5.0 4.0 3.0 2.0 1.0
Figure 5.5 NMR spectrum of CS5-SATA. SATA-derived signals are labeled with
asterisks.
J
117
i30 mg/ml
Temperature (''C)
Figure 5.6 LCST behavior of CS5-SATA protein at 10, 20, and 30 mg/ml
concentrations.
0.18-,
Strain (%)
Figure 5.7 Stress-strain behavior of disulfide crosslinked CS5-SATA protein films.
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0.08-1
Figure 5.8 Determination of shear modulus, G, of disulfide crosslinked CS5-SATA
protein films.
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0.025 -,
0.020 -
to 0.015
Q-
(0W 0.010-
0.005 -
0.000
E = 0.46 + 0.03 MPa
^
r
1
T r
2
1 ^
4
Strain (%)
Figure 5.9 Determination of the tensile or Young's modulus, E, of CS5-SATA
protein films.
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CHAPTER 6
HUVEC ADHESION TO CSS AND SCS PROTEINS
6.1 Introduction and Ohjertivpg
Equally important to the mechanical properties of a vascular graft material are the
biologic properties. Adhesion to the REDV sequence has been shown in the CSS
domainLl-5J, but this is the first time a scrambled version of the CSS has been used in an
elastin-like protein as the negative control. The adhesion differences between the CSS
and SCS can be attributed entirely to the scrambling of the REDV to REVD. In this
study the adhesion strengths of human umbilical vein endothelial cells (HUVEC) on CSS
and SCS proteins are investigated and compared to adhesion on fibronectin and BSA.
6.2 Experimental Section
6.2.1 Substrate Preparation
Substrates were prepared for adhesion studies by adsorbing three wells each of a
96-well plate with 75 |al of 1 mg/ml solutions of fibronectin, CSS, and SCS for at least 1
hr at 4 °C. The excess protein was removed and 7S ).il 1 mg/ml heal inactivated Bovine
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Scrum Albumin (BSA) was added ,„ ,hc wells co,„a,„in, ,he adsorbed substrates and 3
additional wells for 30 ntin. The wells were r.nsed with 100 ,1 PBS three ti.es and kept
in PBS until use,
6.2.2 Culturintz linv^r
IIUVHC (Clonetics, San Diego, CA) were used in the adhesion assays from
passage two through live. The eells were grown on 100 mm tissue eulture polystyrene
culture dishes. The culture medium was EGM-2 (Clonetics, San Diego, CA) that
contains serum and growth factors.
6.2.3 Fluorescent Labeling' of IIUVEC
The IIUVEC were lluorescently labeled with 2\ 7'-bis-(2-carboxyethyl)-5-(and-
6)-carboxynuorescein (RCECF-AM) (Molecular Probes, Inc., Eugene, Oregon). The
culture medium was aspirated from the IIUVEC, washed twice with 5 ml PBS, and 5 ml
of PBS + 0.2 % EDTA was added to the dish. This was allowed to incubate 10 min at 25
°C before tapping the dish to detach the loosened cells and harvesting the detached cells
into a centriluge tube. The cells were centrifuged at 800 g for 5 min. The supernatant
was decanted and the cell pellet was rcdispcrsed in 1 ml serum and growth factor free
medium EBlVI-2 (Clonetics, San Diego, CA). A 10 niM stock solution of BCECF-AM
was prepared in DMSO. A 2 aliquot was added to the rcdispcrsed cells and allowed to
incubate at 4 °C for 30 min. PBS ( 1 0 ml) was added to the cell suspension and this was
124
centrifuged (800 g, 5 min). This step was repeated and the resultant pellet was counted
for cell number and viability in PBS containing Mg^^and Ca^^ cations (PBS+).
6.2.4 Plating ofHTJVFr
HUVEC were plated at a density of 4 x lO^ells/well in PBS+ and incubated 30
min at 37 °C and 5 % CO2 atmosphere.
6.2.5 Detachment by Centrifiipatinn
Percoll (200 ^1) (Sigma Chemical Co., St. Louis, MO) was added gently down the
side of each well for three separate prepared 96-well plates after incubation with
HUVEC. One plate each was centrifuged at 1 g, 1000 g, and 3000 g for 10 min. After
centrifugation, the PBS+ and Percoll/PBS+ interface (includes detached cells) were
wicked away with a height-adjusted 4x12 Skatron harvesting frame (Molecular Devices)
leaving only a small amount of Percoll in each well. The remaining Percoll was then
aspirated from the wells. PBS (100 |al) was added to each well. Plates were either read
by a fluorescent plate reader at an excitation/emission of 485/535 nm or stained with
Crystal Violet as follows.
125
^•2-6 Crystal Violet Staininp of AHh^T;g£jjny£^
After centrifugation the PBS was aspirated from the wells and 100 ^\ of a 70 o/o
EtOH/H20 solution was added to each well and incubated at 25 °C for 15 min. The
EtOH solution was removed and 100 ,1 of a 1 o/„ crystal violet solution in H.O was added
to each well and incubated for 30 min. The crystal violet solution was removed and
washed with 250 ^1 H,0 to each well five times. A 2 o/o SDS solution in H,0 (100 m)
was added to each well and allowed to solubilize for 12 hr. The plate was read for
absorbance at 598 nm on a plate reader.
6.3 Results and Discussion
6.3.1 Substrate Preparation
IS a
Adsorption of the protein to the surface of a polystyrene tissue culture plate
common method for studying the interactions of cells with different proteins [6]. The
subsequent addition of heat inactivated BSA blocks nonspecific adhesion sites, allowing
the study of the specific interactions of the cell with the test protein.
Fibronectin served as the positive control protein and was expected to show good
HUVEC adhesion. HUVEC can adhere through several cell-binding domains within
fibronectin targeting different integrins. As described in Chapter 1 , the ROD can attach
the asp] and a^^3 integrins whereas the CS5 and CSl domains adhere through the a4pi
integrin. BSA blocked polystyrene served as a negative control.
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6-3.2 Fluorescent Labelinp ofHUVEC
The acetoxymethyl ester, BCECF-AM, is membrane permeable and
nonfluorescent. As the ester is assimilated into the cell, the intracellular esterases
hydrolyze the ester into a membrane impenneable, fluorescent form. For this reason, the
dye only fluoresces in viable cells, ensuring metabolically inactive cells are not
measured. The fluorescent derivative is pH sensitive; it is possible that downstream
events from integrin binding of the cells can affect the intracellular pH. This concern
instigated the use of another staining method to substantiate the fluorescence
measurements.
The standard curve for labeled HUVEC is shown in Figure 6.2. It shows a li
emission dependence on concentration of cells. Calibration was done on individual
experiments and day-to-day differences of absolute values of fluorescence were observed
due to variations in uptake of dye. Therefore, the detachment is not expressed in cell
numbers, but instead as the mean of three replicated values.
mear
6.3.3 Detachment bv Centrifugation
In order to apply a uniform, well defined, detachment force to the HUVEC the
PBS+ is displaced with a denser Percoll solution and upon upright centrifugation a
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buoyant force is applied ,o *e cells. In .his way, ,hc strength of attachment can be
investigated by direct centrifugation of the 96-well plate at difTcrent relative centrifugal
forces [6].
The force applied to each cell can be represented by Archimedes' Theorem:
F= (pc - Pm) Vc (RCF) (4) 1 5]
Where p. is the density of the cell, p.. is the density of the medium, v. is the volume of
the cell, and RCF are the relative centrifugal force. The cell to substrate adhesion
strength must be greater than the applied force for the cell to remain attached. Density
marker beads to produce gradients in the Percoll could be used for determining HUVEC
density and a Coulter counter for determining volume. For the purposes of this study, the
relative attachment forces are being investigated with respect to controls, eliminating the
need for absolute numbers. However, as a reference, the density and volume of a cell
can be taken from the known values for a human fibrosarcoma cell CCL 121 as 1 .046
g/ml and 1.455 nl. The density of the medium (Percoll diluted in lOx PBS) is 1.123 g/ml.
Using these numbers to get a general idea, the force at Ig RCF on one cell in Percoll is
0.1 12 iLidynes.
6.3.4 HUVEC Adhesion to CS5 and SC5 Proteins
The results arc background subtracted by negative control wells with no cells
added and presented as the mean of three replicated values. The experiment was repeated
three times to confirm consistency. Due to variation in absolute numbers, the reported
result is from one of the experiments. Table 6.1 gives the relative adhesion of the
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dilTcrent substrates compared to llbronectin. Figure 6.3 shows the relative fluorescence
emission versus RCF for llbronectin, CSS, SC5, and RSA. UimiC adhesion at 1 g to
CSS is similar to fibronectin whereas the adhesion to SCS is 1 S % of adhesion to
fibronectin (similar to BSA). As the force is increased to 1000 g the IIUVEC still show
adhesion to the CSS, but the SCS shows little or no adhesion, again similar to the BSA.
The adhesion to CSS is 66 % of the adhesion to llbronectin. At 3000 g there is
significant detachment of the IlUVIiC to the CSS, only 23 % of the HUVFX remain
compared to fibronectin. Although adhesion is lower to CSS than to fibronectin, this is
not unexpected since there are other types of cell-binding domains in fibronectin and only
the RHDV in CSS.
Figure 6.4 shows the experimental results of the cry.slal violet staining method.
The trends shown in the lluorcsccncc experiment are confirmed by this method.
The differences between adhesion on CSS and SCS indicate adhesion to the CSS
occurs through the RFDV cell-binding domain since the only dilTerence in sequence is
the REDV scrambled to REVD.
6.4 Summarv and Conclusions
IIUVEC showed significantly stronger adhesion to CSS than SCS. SCS shows
little or no IIUVEC adhesion at any detachment force, similar to BSA. This result
indicates IIUVEC is mediated by the RliDV sequence in the CSS domain.
This study complements the results in a recently published article describing
HUVEC interactions with CSS containing elastin-Iike proteins |7|. It was found that the
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soluble peptide GREDVDY inhibited HUVEC adhesion 97 % while no decrease in
adhesion was seen with the sequence scrambled GREVDDY.
These results suggest this class of materials could be promising for application in
vascular grafts. Studies of cell interactions are being continued on CSS and SC5 as well
as on CS
1
and variants with different cell-binding domains.
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Relative Adhesion at RCF
Substrate lg loppg gpopq
Fibronectin 1.00 1.00 1.00
CS5 1.06 0.66 o'23
SC5 0.15 0.05 0 02
BSA 0.00 0.13 0.04
No Cells 0.00 0.00 0.00
Table 6.
1
HUVEC adhesion to substrates relative to fibronectin
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HjC^OHsCOC
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CCH3
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o
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II ' II
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t
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II II i
o o A
MW = 556.5
Figure 6. 1 The fluorescent label BCECF-AM
molecules.
is a mixture of the above three
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2500
10
Number of Cells (xlO^)
Figure 6.2 Standard curve for the labeled HUVEC showing linear dependence of
fluorescence emission at 535 nm with number of cells.
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Figure 6.3 HUVEC adhesion, measured in fluorescence, to CSS and SC5 relative to
fibronectin and BSA.
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Figure 6.4
500 1000 1500 2000 2500
Centrifugal Force (g)
3000
HUVEC adhesion, measured by crystal violet staining, to CSS and SC5
relative to fibronectin and BSA.
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CHAPTER 7
FUTURE RESEARCH DIRECTIONS
"^-l Mechanical and Biological rnndH^ration-;
Sufficient tear resistance is an essential property for a vascular graft material. The
material would generally need to be sutured into place and potentially need to resist
failure if injured. The crosslinked artificial ECM (aECM) proteins described here have
very low tear resistance. The materials are amorphous with nothing to inhibit crack
propagation. The films crosslinked above the LCST show slightly better tear resistance
as might be expected from an inhomogeneous sample but still much too low for
suturability.
It is possible the protein could be crosslinked around a woven mesh or fabric that
would serve to stop crack propagation. This could be used in the form of a complete
graft or as a cuff Increasing the crosslink density at the ends of the graft would toughen
the material but also cause a compliance mismatch with the native vessel. The creation
of suturing eyelets could circumvent this issue, but could be too tedious to be reasonable.
Fillers could improve the tear resistance. Such possibilities would include the
hydrolysis of tetraethoxysilane(TEOS) to precipitate very small, well-dispersed particles
into a crosslinked film [1].
Tear resistance is another major obstacle to overcome before these aECM protein
materials can be used for testing as a vascular graft material.
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Adhesion ofHUVEC as well as other eell types sueh as smooth tnuscle cells,
fibroblasts, platelets and leukocytes will need to be studied further to elucidate the
interactions of these cells with the aECM protein. Alternative cell-binding domains have
already been incorporated in similar aECM proteins and are being studied. In addition,
growth factors and heparin-binding domains should be considered. It is possible that a
combination of these different types ofdomains would serve as a better vascular graft.
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APPENDIX
LIST OF AMINO ACIDS
ALIPHATIC
Glyc,n=,G„G, Alanine ,A,. A) Val.ne (Val V, Uu=ine,UuL, Uoleucinc (Uc )
"»-X*0„ H,.^„„ „,^^^ 0
AROMATIC
Phenylalanine (Phe F)
H.
BASIC
Lysine (Lys K)
Tyrosine (lyr Y)
OH
Arginine (Arg R)
N NH2
Tryptophan (Trp W)
H2.
Histidine (His H)
nTnh
CYCLIC
Proline (Pro P)
OH
ACIDIC
Aspartic Acid (Asp D)
OH
Glutamic Acid (Glu E) Asparagine (Asn N)
O^OH NH2
Glutamine (Gin Q)
HYDROXYL OR SULFUR CONTAINING
Serine (Ser S) Cysteine (Cys C) Threonine (Thr T) Methionine (Met M) Homocysteine (Hey)
H^K^OH H^^^o^ ^2K^oH
»^\^0HOH
SH
O
OH
SH
Frecuisoi 'o
methionine
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